Becton, Dickinson and Company (0R19.L)
USD 227.72
(1.16%)
USD 227.72
(1.16%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 15.87 Billion USD | -0.95% |
| 2022 | 16.56 Billion USD | -8.37% |
| 2021 | 18.08 Billion USD | -1.59% |
| 2020 | 18.37 Billion USD | -5.24% |
| 2019 | 19.39 Billion USD | -9.79% |
| 2018 | 21.49 Billion USD | 13.91% |
| 2017 | 18.87 Billion USD | 63.36% |
| 2016 | 11.55 Billion USD | -9.91% |
| 2015 | 12.82 Billion USD | 222.89% |
| 2014 | 3.97 Billion USD | 0.03% |
| 2013 | 3.97 Billion USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 16.11 Billion USD | -1.83% |
| 2024 Q3 | 19.32 Billion USD | 7.28% |
| 2024 Q2 | 18.01 Billion USD | 11.8% |
| 2023 Q1 | 16.45 Billion USD | -0.67% |
| 2023 Q4 | 16.41 Billion USD | -2.22% |
| 2023 FY | 16.41 Billion USD | -0.95% |
| 2023 Q3 | 16.78 Billion USD | -7.91% |
| 2023 Q2 | 18.22 Billion USD | 10.74% |
| 2022 FY | 16.56 Billion USD | -8.37% |
| 2022 Q3 | 16.36 Billion USD | -12.18% |
| 2022 Q4 | 16.56 Billion USD | 1.23% |
| 2022 Q2 | 18.63 Billion USD | 6.95% |
| 2022 Q1 | 17.42 Billion USD | -3.63% |
| 2021 FY | 18.08 Billion USD | -1.59% |
| 2021 Q3 | 17.73 Billion USD | 0.08% |
| 2021 Q1 | 17.81 Billion USD | -2.45% |
| 2021 Q2 | 17.71 Billion USD | -0.56% |
| 2021 Q4 | 18.08 Billion USD | 1.96% |
| 2020 FY | 18.37 Billion USD | -5.24% |
| 2020 Q4 | 18.26 Billion USD | -4.16% |
| 2020 Q2 | 21.51 Billion USD | 8.94% |
| 2020 Q3 | 19.05 Billion USD | -11.4% |
| 2020 Q1 | 19.74 Billion USD | 1.83% |
| 2019 FY | 19.39 Billion USD | -9.79% |
| 2019 Q4 | 19.39 Billion USD | -3.93% |
| 2019 Q2 | 20.61 Billion USD | -2.17% |
| 2019 Q3 | 20.18 Billion USD | -2.08% |
| 2019 Q1 | 21.07 Billion USD | -1.97% |
| 2018 FY | 21.49 Billion USD | 13.91% |
| 2018 Q4 | 21.49 Billion USD | -3.39% |
| 2018 Q3 | 22.25 Billion USD | -2.37% |
| 2018 Q2 | 22.79 Billion USD | -0.03% |
| 2018 Q1 | 22.79 Billion USD | 20.82% |
| 2017 Q1 | 11.01 Billion USD | -4.77% |
| 2017 Q2 | 10.31 Billion USD | -6.42% |
| 2017 Q3 | 19.01 Billion USD | 84.44% |
| 2017 Q4 | 18.87 Billion USD | -0.77% |
| 2017 FY | 18.87 Billion USD | 63.36% |
| 2016 Q1 | 12.8 Billion USD | -0.1% |
| 2016 FY | 11.55 Billion USD | -9.91% |
| 2016 Q4 | 11.56 Billion USD | -3.03% |
| 2016 Q3 | 11.93 Billion USD | -4.69% |
| 2016 Q2 | 12.51 Billion USD | -2.27% |
| 2015 Q2 | 13.83 Billion USD | 36.44% |
| 2015 Q1 | 10.14 Billion USD | 155.4% |
| 2015 Q3 | 13.17 Billion USD | -4.82% |
| 2015 Q4 | 12.82 Billion USD | -2.65% |
| 2015 FY | 12.82 Billion USD | 222.89% |
| 2014 Q1 | 3.96 Billion USD | -0.03% |
| 2014 FY | 3.97 Billion USD | 0.03% |
| 2014 Q2 | 3.96 Billion USD | -0.08% |
| 2014 Q3 | 3.97 Billion USD | 0.18% |
| 2014 Q4 | 3.97 Billion USD | -0.05% |
| 2013 Q2 | 4.16 Billion USD | 0.0% |
| 2013 Q3 | 3.96 Billion USD | -4.79% |
| 2013 Q4 | 3.97 Billion USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | 3.97 Billion USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -132412.726% |
| Accuray Incorporated | 172.15 Million USD | -9123.611% |
| Align Technology, Inc. | 96.96 Million USD | -16275.505% |
| Elevance Health Inc. | 25.12 Billion USD | 36.787% |
| AxoGen, Inc. | 69.29 Million USD | -22816.065% |
| Boston Scientific Corporation | 9.09 Billion USD | -74.552% |
| CVS Health Corporation | 79.38 Billion USD | 79.997% |
| Cardinal Health, Inc. | 5.6 Billion USD | -183.099% |
| Centene Corporation | 17.69 Billion USD | 10.283% |
| DaVita Inc. | 11.11 Billion USD | -42.843% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 62.066% |
| Hologic, Inc. | 2.53 Billion USD | -526.489% |
| Humana Inc. | 10.21 Billion USD | -55.478% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -1575.212% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | -166.686% |
| Masimo Corporation | 970 Million USD | -1537.01% |
| McKesson Corporation | 5.47 Billion USD | -190.186% |
| Patterson Companies, Inc. | 762.94 Million USD | -1981.291% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | -195.753% |
| ResMed Inc. | 873.93 Million USD | -1716.954% |
| Henry Schein, Inc. | 2.74 Billion USD | -479.314% |
| Teladoc Health, Inc. | 1.59 Billion USD | -897.251% |
| Universal Health Services, Inc. | 5.36 Billion USD | -195.884% |
| Veeva Systems Inc. | 55.77 Million USD | -28369.745% |
| Baxter International Inc. | 14.36 Billion USD | -10.547% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -17582.628% |
| Danaher Corporation | 19.35 Billion USD | 17.963% |
| Stryker Corporation | 12.99 Billion USD | -22.193% |
| Medtronic plc | 24.96 Billion USD | 36.39% |